PTC Therapeutics approved stock options for 10,050 shares and 11,870 restricted stock units (RSUs) to 18 new employees as part of their compensation. The grants, made under Nasdaq inducement rules, have a $74.71 exercise price and vest over four years. This move aims to attract talent by offering equity incentives tied to continued employment. PTC is a biopharma company focused on treatments for rare disorders.
Ultragenyx Pharmaceutical Inc. awarded 44,409 restricted stock units to 15 newly hired non-executive officers under its Employment Inducement Plan. The grants, approved by the compensation committee, vest over four years with 25% vesting annually, co...
Nyxoah has announced an extraordinary general meeting of shareholders set for July 9, 2026, at its headquarters in Belgium. The meeting will discuss renewing the authorization for the board to increase the company's capital over the next five years, ...
Eupraxia Pharmaceuticals held its Annual General Meeting on June 18, 2026, where shareholders elected all seven board nominees proposed by management with strong majority votes. Additionally, KPMG LLP was reappointed as the company's auditor for the ...
Cate & Chloe is discounting its Bianca 18k Gold-Plated Crystal Hoop Earrings to $19.98 from $86 during Amazon Prime Day 2026, running June 23-26. This 77% markdown aligns with growing consumer demand for affordable luxury jewelry, with earrings price...
Conifex Timber Inc. held its annual general meeting on June 19, 2026, where all management nominees were successfully elected as directors with over 95% of votes in favor. Shareholders also approved the appointment of PricewaterhouseCoopers LLP as th...
